Cervicitis by Iontophoresis
Early Phase 1
Not yet recruiting
- Conditions
- CERVICITIS
- Interventions
- Device: IONTOPHORESISDrug: ORAL ANTIBIOTIC
- Registration Number
- NCT05675293
- Lead Sponsor
- October 6 University
- Brief Summary
The purpose of the study is to:
Investigate effect of iontophoresis on managing uterine cervicitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
- All patients have vaginal discharge.
- All patients have irregular vaginal bleeding, especially after sexual intercourse.
- All patients have dyspareunia.
- All patients have Lower abdominal pain.
- Group A: 20 women will receive oral medication (antibiotic zesrosin) and hot water with antiseptic.
- Group B: 20 women will receive medication by iontophoresis (antibiotic ceftriaxone) and hot water with antiseptic.
Exclusion Criteria
- Patients with a history of hypersensitivity or adverse reactions associated with the delivered drug in (ceftriaxone).
- Patients with prior medical histories of cardiac arrhythmias or hypercoagulability should not receive the procedure near cardiac pacemakers and superficial blood vessels.
- In the vicinity of embedded wires, stapes, orthopedic implants, and areas of skin with lesions and impaired sensation.
- It either should not be used or used with extreme caution during pregnancy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description EXPERIMENTAL ARM IONTOPHORESIS - CONTROL ARM ORAL ANTIBIOTIC -
- Primary Outcome Measures
Name Time Method Difference in change in Urine Analysis and Cervical swab results in both groups 7 Days difference between pre and post tests Presence of Pus Cells in Urine Analysis and a Positive Cervical swab results
- Secondary Outcome Measures
Name Time Method